Defining and enhancing collaboration between community pharmacists and primary care providers to improve medication safety
Annesha White,Kimberly G. Fulda,Rachel Blythe,Michelle A. Chui,Emily Reeve,Richard Young,Anna Espinoza,Noah Hendrix,Yan Xiao
DOI: https://doi.org/10.1080/14740338.2022.2147923
2022-11-22
Expert Opinion on Drug Safety
Abstract:Over 4 billion prescriptions are dispensed each year to patients in the United States, with the number of prescriptions continuing to increase. There is a growing recognition of pharmacists' potential in improving medication safety in community settings, in collaboration with primary care providers (PCPs). However, the nature of collaboration has not been well defined, and barriers and strategies are not articulated. For this narrative review, published studies were retrieved from PubMed between January 2000 and December 2020. Search terms included "patient safety," "medication safety," "collaboration," "primary care physician," and "community pharmacy." Resulting articles were categorized as follows: defining collaboration, types of collaboration, and barriers and solutions to collaboration. It is important to understand the factors within a community pharmacy setting that limit or facilitate community pharmacists' participation in medication safety activities. Strategies such as medication review are a common form of collaboration. Barriers to collaboration include misconceptions regarding roles and differences in access to clinical information and community pharmacy practice variability. Future recommendations include increasing training and utilization of pharmacists/PCP teams, increasing community pharmacists' practice in emerging roles, and expanding the community pharmacist role in transitions of care from the hospital to the community.
pharmacology & pharmacy
What problem does this paper attempt to address?